SEI Investments’s Cogent Biosciences COGT Stock Holding History

SEI Investments’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.25M	Sell	161,522 -35,988	-18%	-$1.26M	0.01%	1375
2026 Q1	$7.6M	Buy	197,510 +18,096	+10%	+$668K	0.01%	1280
2025 Q4	$6.37M	Buy	179,414 +168,090	+1,484%	+$4.73M	0.01%	1267
2025 Q3	$163K	Buy	+11,324	New	+$134K	﹤0.01%	2655
2022 Q4	–	Sell	-37,810	Closed	-$564K	–	2556
2022 Q3	$564K	Sell	37,810 -8,010	-17%	-$110K	﹤0.01%	2029
2022 Q2	$413K	Buy	+45,820	New	+$313K	﹤0.01%	2180

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SEI Investments's COGT Position: Q2 2026 in Review

SEI Investments reduced its Cogent Biosciences (COGT) stake by 18% in Q2 2026, selling an estimated $1.26M and leaving 161,522 shares worth $6.25M. The position accounts for 0.01% of the portfolio, ranked #1375.

SEI Investments first reported a position in COGT in Q2 2022 and has held it in 6 quarters since. The position peaked at $7.6M in Q1 2026. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

SEI Investments held 161,522 shares of Cogent Biosciences worth $6.25M as of Q2 2026.
SEI Investments sold 35,988 Cogent Biosciences shares in Q2 2026, an estimated $1.26M.
Cogent Biosciences made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1375 holding.
SEI Investments first reported a position in Cogent Biosciences in Q2 2022 and has held it in 6 quarters since.
SEI Investments's Cogent Biosciences position peaked at $7.6M in Q1 2026.
322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.